IMC Chicago
TECH icon

IMC Chicago’s Bio-Techne TECH Stock Holding History

IMC Chicago’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
29,000
+4,700
+19% +$282K ﹤0.01% 2849
2025
Q4 		$1.43M Buy
+24,300
New +$1.48M ﹤0.01% 2696

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IMC Chicago's TECH Position: Q1 2026 in Review

IMC Chicago reduced its Bio-Techne (TECH) stake by 67% in Q1 2026, selling an estimated $615K and leaving 5,160 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #4714.

IMC Chicago first reported a position in TECH in Q4 2025 and has held it in 2 quarters since. The position peaked at $906K in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • IMC Chicago held 5,160 shares of Bio-Techne worth $270K as of Q1 2026.
  • IMC Chicago sold 10,252 Bio-Techne shares in Q1 2026, an estimated $615K.
  • Bio-Techne made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4714 holding.
  • IMC Chicago first reported a position in Bio-Techne in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Bio-Techne position peaked at $906K in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.